Pacific Biosciences of California, Inc. (PACB) Posts Q2 EPS Loss of $0.42

Pacific Biosciences of California, Inc. (NASDAQ: PACB) reported Q2 EPS of ($0.42), $0.20 better than the analyst estimate of ($0.62). Revenue for the quarter came in at $10.6 million versus the consensus estimate of $4.1 million.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• MillerKnoll, Inc. (MLKN) Tops Q1 EPS by 18c ; Offers Guidance
• Dave & Buster's Entertainment (PLAY) Misses Q2 EPS by 46c
• LuxExperience B.V. (LUXE) Misses Q2 EPS by 11c